Extensive research has shown that hormonal therapies can help control advanced prostate cancer for a time. However, for most men, at some point their prostate cancer eventually stops responding to further hormonal treatment. This stage of the disease is called androgen-insensitive or castration-resistant prostate cancer. In a study published March 18 in iCancer Cell/i, a team led by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) ...
View the Original article
